Genetic Polymorphisms of the ß2-Adrenergic Receptor Relate to Guanosine Protein-coupled Stimulator Receptor Dysfunction in Fibromyalgia Syndrome
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objective.: To determine the genotype frequencies of ß 2-adrenergic receptor (ß 2 AR) gene polymorphisms (Gly16Arg, Glu27Gln) in patients with fibromyalgia syndrome (FM) by comparison with unrelated healthy controls. We sought any clinical association with these polymorphisms and determined whether the polymorphisms would associate with a biologic guanosine protein-coupled stimulator receptor (Gs) dysfunction in FM. Methods.: Study subjects included 97 clinically characterized patients with FM and 59 controls. The ß 2 AR polymorphisms at codons 16 and 27 were determined using polymerase chain reaction-restriction fragment length polymorphism. The Gs functions of peripheral blood mononuclear cells (PBMC) were tested using isoproterenol (ISO) as the adrenergic Gs ligand and measuring intracellular cyclic adenosine monophosphate (cAMP) levels. Results.: The frequency of the ß 2 AR gene polymorphism Gly16Arg in FM (43.5%) was significantly lower than in controls (63.2%), suggesting that this genotype might have some effect on the risk of developing FM. The only clinical association in FM was with sleep dysfunction. Patients with FM who carried the ß 2 AR polymorphism Arg16Arg also exhibited significantly lower PBMC basal cAMP levels (p < 0.05) and lower ISO-stimulated cAMP levels (p < 0.05) than FM carrying Gly16Gly or Gly16Arg. Conclusion.: This confirms a relationship between ß 2 AR polymorphism and FM. It is the first study to demonstrate ß 2 AR polymorphism-related differences in intracellular cAMP responses of FM PBMC after ß 2 AR stimulation in vitro. These findings may explain some of the differences in responsiveness of FM subgroups to the adrenergic agonist medications currently approved for FM treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elenkov, I. J., Wilder, R. L., Chrousos, G. P., & Vizi, E. S. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01470-4 · Cited by 2,252
The effects of sleep deprivation on pain inhibition and spontaneous pain in women
Smith, M. T., Edwards, R. R., McCann, U. D., & Haythornthwaite, J. A. (2007) · Sleep · doi:10.1093/sleep/30.4.494 · Cited by 539
Arnold, L. M., Hudson, J. I., Hess, E. V., Ware, A. E., Fritz, D. A., Auchenbach, M. B., Starck, L. O., & Keck, P. E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20042 · Cited by 454
Russell, J. I., Mease, P. J., Smith, T. R., Kajdasz, D. K., Wohlreich, M. M., Detke, M. J., Walker, D. J., Chappell, A. S., & Arnold, L. M. (2008) · Pain · doi:10.1016/j.pain.2008.02.024 · Cited by 367
Pharmacology and physiology of human adrenergic receptor polymorphisms
Small, K. M., McGraw, D. W., & Liggett, S. B. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135823 · Cited by 323
Miller, G. E., & Chen, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506312103 · Cited by 199
Biology and therapy of fibromyalgia. New therapies in fibromyalgia.
Arnold (2006) · Arthritis Research & Therapy · doi:10.1186/ar1971 · Cited by 145 · cited 1×
“A better understanding of the pathophysiology and the molecular mechanisms underlying the development and persistence of FM would represent a step toward more effective treatment 6,7 .”
BackgroundAssessment of Patients with Fibromyalgia Syndrome
Mease, P. J. (2008) · Journal of Musculoskeletal Pain · doi:10.1080/10582450801960347 · Cited by 20
Cited by
Fibromyalgia: A Critical and Comprehensive Review
Borchers, A. T., & Gershwin, M. E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8509-4 · Cited by 275
The phenotypic and genetic signatures of common musculoskeletal pain conditions
Diatchenko, L., Fillingim, R. B., Smith, S. B., & Maixner, W. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.43 · Cited by 241
Deere, K. C., Clinch, J., Holliday, K., McBeth, J., Crawley, E. M., Sayers, A., Palmer, S., Doerner, R., Clark, E. M., & Tobias, J. H. (2012) · Pain · doi:10.1016/j.pain.2012.06.006 · Cited by 136
“Several risk factors for chronic musculoskeletal pain in children have been postulated, which may contribute to its pathogenesis, including behavioural/psychological factors [33], early adversity [35], joint hypermobility [1], abnormalities of the Hypothalamic– pituitary–adrenal axis [20], and genetic risk factors [39…”
BackgroundHuijnen, I. P. J., Rusu, A. C., Scholich, S., Meloto, C. B., & Diatchenko, L. (2015) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000000100 · Cited by 44
Programmed Symptoms: Disparate Effects United by Purpose
Gracely, R., & Schweinhardt, P. (2015) · Current Rheumatology Reviews · doi:10.2174/1573397111666150619095125 · Cited by 23
“Interestingly, the adrenergic pathway genes ADRB2 and COMT have been associated with numerous endophenotypes associated with FM, including autonomic dysregulation [66], alterations in pain processing and modulation [67, 68], sleep dysfunction [69, 70], and anxiety [66, 71].”
Background
Metadata
- Authors
- XIAO, Y., HE, W., & RUSSELL, I. J.
- Venue
- The Journal of Rheumatology
- Publisher
- The Journal of Rheumatology
- Published
- 2011-03-15
- Volume
- 38
- Issue
- 6
- Pages
- 1095-1103
- ISSN
- 0315-162X (ISSN-L)
- 1499-2752
- OpenAlex
- W2036255519
- Cited by
- 37
- References
- 8
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic Polymorphisms of the ß2-Adrenergic Receptor Relate to Guanosine Protein-coupled Stimulator Receptor Dysfunction in Fibromyalgia Syndrome. https://app.cochat.ai/papers/10.3899/jrheum.101104
- The paper
- XIAO, Y., HE, W., & RUSSELL, I. J. (2011). Genetic Polymorphisms of the ß2-Adrenergic Receptor Relate to Guanosine Protein-coupled Stimulator Receptor Dysfunction in Fibromyalgia Syndrome. The Journal of Rheumatology. https://doi.org/10.3899/jrheum.101104
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.